Aflac Incorporated Website

Aflac Incorporated

NYSE-AFL

Company Overview

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.

  • Name

    Aflac Incorporated

  • CEO

    Daniel Paul Amos

  • Website

    www.aflac.com

  • Sector

    Insurance

  • Year Founded

    1955

Company Statistics

Profile

  • Market Cap

    —

  • EV

    —

  • Shares Out

    —

  • Revenue

    —

  • Employees

    —

Margins

  • Gross

    —

  • EBITDA

    —

  • Operating

    —

  • Pre-Tax

    —

  • Net

    —

  • FCF

    —

Returns (5Yr Avg)

  • ROA

    —

  • ROTA

    —

  • ROE

    —

  • ROCE

    —

  • ROIC

    —

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    —

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    —

  • Net Debt

    —

  • Debt/Equity

    —

  • EBIT/Interest

    —

Growth (CAGR)

  • Rev 3Yr

    —

  • Rev 5Yr

    —

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    —

  • Dil EPS 5Yr

    —

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    —

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    —

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

What's happening

Nov 12, 2025 - Dec 12, 2025

Aflac Inc Faces Investor Skepticism Amid Insider Selling and Market Pressures

  • Aflac's stock declined by 5.8% over the past month, significantly underperforming the S&P 500's gain of 0.7%.
  • Significant insider selling activities raised concerns about executive confidence and company prospects.
  • Despite positive initiatives like a children's book launch, investor sentiment remained negative due to broader market pressures.

Over the past month, Aflac Inc. experienced a decline of 5.8% in its stock performance, which is notably lower than the S&P 500's modest gain of 0.7%. This downturn was largely driven by bearish events that heightened investor concerns regarding executive confidence and overall company outlook. Notably, Vice President Beaver sold 3,452 shares shortly before this period ended; such insider selling often signals uncertainty about future performance.

Compounding these issues were significant transactions involving Senior Executive Vice President Tillman Audrey B., who exercised an option to buy shares at $28.97 and subsequently sold them at $112 each on November 18th. Such actions from high-ranking executives can lead shareholders to question the company's future prospects further. Additionally, another sale by Vice President Tillman just days later amounted to approximately $397,300, adding scrutiny to Aflac’s stock performance.

Although Aflac initiated some positive efforts aimed at enhancing its brand image—such as launching a children's book titled "Beyond Words" intended for children with cancer—these initiatives did not yield favorable reactions from investors during this timeframe. The release showcased Aflac's commitment but coincided with prevailing negative trends affecting market sentiment.

Aflac also announced a quarterly dividend increase while maintaining its history of annual increases over more than four decades; however, even this announcement failed to significantly boost investor confidence amid ongoing bearish pressures in financial markets surrounding stocks like AFL. Overall, despite attempts by Aflac to engage positively with its community through dividends and philanthropic initiatives, substantial insider selling activities overshadowed these efforts along with general market apprehensions regarding executive actions within the company itself.

Aflac Inc underperformed the Financials (XLF) sector by -9%.

NYSE:AFL